C
Confo Therapeutics
1 follower
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior s... Read more
Org chart
Collapse
Frank Landolt
Chief Counsel, Intellectual Property & Legal
Paolo Vicini
Chief Development Officer
Marc Moens
Head, Finance & HR
Stephanie Staelens
Project Manager, Early Drug Discovery
Stephen Dowd
Chief Business Officer
Geert Degruyter
System Administrator
Board & advisors
Edward van Wezel
Board Director
Jan Steyaert
Founder & Chairman, Scientific Advisory Board
John Berriman
Chairman
Rob Scott
Independent Director
Radu Aricescu
Scientific Advisory Board Member
Peter Kolb
Scientific Advisory Board Member
Graeme Milligan
Scientific Advisory Board Member
Jos B. Peeters
Director
Filip Goossens
Director
Karl Nägler
Director
Tim Corn
Medical Advisor